The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 01, 2025
Filed:
Oct. 06, 2021
Applicant:
Mapi Pharma Ltd., Ness Ziona, IL;
Inventors:
Uri Danon, Tel Aviv, IL;
Nadav Bleich Kimelman, Tel Aviv, IL;
Laura Popper, Tel Aviv, IL;
Ehud Marom, Tel Aviv, IL;
Assignee:
MAPI PHARMA LTD., Ness Ziona, IL;
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 9/00 (2006.01); A61K 38/02 (2006.01); A61K 47/34 (2017.01); A61P 25/00 (2006.01); A61P 25/28 (2006.01); A61K 38/10 (2006.01); A61K 38/16 (2006.01); A61K 39/00 (2006.01); C07K 14/47 (2006.01);
U.S. Cl.
CPC ...
A61K 38/02 (2013.01); A61K 9/0024 (2013.01); A61K 47/34 (2013.01); A61P 25/00 (2018.01); A61P 25/28 (2018.01); A61K 38/10 (2013.01); A61K 38/16 (2013.01); A61K 39/0008 (2013.01); C07K 14/4713 (2013.01); G01N 2800/285 (2013.01);
Abstract
The present invention provides methods for treating or ameliorating primary progressive multiple sclerosis (PPMS) or secondary progressive multiple sclerosis (SPMS) and related symptoms by administering or implanting a depot formulation comprising glatiramer salts, such as glatiramer acetate (GA).